Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis
Osteoporosis International, 06/05/09
Pirro M et al. – Study reports that in postmenopausal osteoporotic women, a reduced number of circulating AP+ cells and increased levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells are associated with reduced bone mineral density (BMD).
Methods- Aim was to investigate if an association exists between the number of circulating osteoprogenitor cells and BMD in postmenopausal women with and w/o osteoporosis
- Number of circulating AP+, osteocalcin-positive (OCN+), AP+/CD34+, and OCN+/CD34+ cells was quantified in 54 postmenopausal osteoporotic women and 36 age-matched nonosteoporotic controls
- Number of AP+ cells was lower in osteoporotic women
- Higher levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells were found in osteoporotic than controls
- Number of AP+ cells was correlated with lumbar BMD and proximal femur BMD
- Whereas inverse correlations were found between AP+/CD34+ cells, OCN+, OCN+/CD34+, and BMD
- Reduced AP+ cells and increased AP+/CD34?+, OCN+, and OCN+/CD34+ cells were predictors of low BMD, independent of traditional risk factors for osteoporosis
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Body Composition and Bone Mineral Density in Children with Premature Adrenarche and the Association of LRP5 Gene Polymorphisms with Bone Mineral Density
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Ethanol extract of Fructus Ligustri Lucidi promotes osteogenesis of mesenchymal stem cells
Phytotherapy Research, 10/13/09
Clock genes, intestinal transport and plasma lipid homeostasis
Trends in Endocrinology and Metabolism, 10/16/09
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Cardiovascular diseases and risk of hip fracture
JAMA, 10/22/09
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150mg and risedronate 150mg
Current Medical Research and Opinion, 10/22/09
Sponsor
Article Search
Sponsor


See Latest Articles


